The Food and Drug Administration, Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services today launched the Tri-Agency Task Force for Emergency Diagnostics, which will work to rapidly develop and deploy diagnostic tests to clinical and public laboratories in an emergency. “Timely implementation of [emergency use authorization] diagnostic assays in the U.S. health care system is dependent upon laboratories understanding the instructions for use and applying them to the patient samples received for testing,” said Kate Goodrich, CMS chief medical officer and director of the Center for Clinical Standards and Quality. “As part of this task force, it is our goal to provide clear and consistent guidance to laboratories on the application of [Clinical Laboratory Improvement Amendments] requirements for these emergency assays.”

Related News Articles

The U.S. Food and Drug Administration May 23 authorized marketing of a diagnostic test for detecting Zika virus antibodies in human blood.
America’s hospitals and health systems are dedicated to doing everything possible for patients, particularly when they need emergency care and as a place for…
The Centers for Disease Control and the National Tuberculosis Controllers Association this week released updated recommendations for TB screening and testing…
The White House yesterday released a strategy to guide the federal government in protecting the nation from infectious disease threats by working with other…
Investing in our country’s health infrastructure is the right move to make.
The Centers for Disease Control and Prevention yesterday reported 695 cases of measles, the most since the virus was eliminated in the U.S. in 2000.